Ensure patient safety and regulatory compliance with advanced UV fluorescence technology that reveals invisible biofilm contamination on reprocessed endoscopes.
Traditional visual inspection methods cannot detect microscopic biofilm residue, putting patients at risk and facilities out of compliance.
Visual inspection alone cannot detect microscopic biofilm residue on endoscope channels
Contaminated endoscopes can transmit infections including CRE, MRSA, and other pathogens
FDA and CDC guidelines require validated cleaning verification methods
Our configurable UV technology — 365 nm (reveals Pseudomonas and moulds with blue/green emission) and 405 nm (reveals porphyrin-rich bacteria including S. aureus and E. coli with red/orange emission), with dual-wavelength configurations available — reveals biofilm contamination completely invisible to the naked eye, providing objective, quantifiable verification of endoscope cleaning effectiveness.
405nm UV light causes biofilm to fluoresce, revealing contamination invisible to the naked eye
Flexible probes access difficult-to-reach areas inside endoscope channels
Capture and store inspection results for regulatory compliance and quality assurance
Videtex UV biofilm detection systems are used by hospitals, ambulatory surgery centers, and endoscopy clinics worldwide to ensure patient safety and regulatory compliance.
Implementing UV biofilm detection delivers measurable improvements in patient safety, compliance, and operational efficiency.
Detect and eliminate biofilm contamination before patient exposure
Meet FDA, CDC, and Joint Commission requirements for cleaning verification
Prevent costly infection outbreaks and reduce scope replacement frequency
Rapid inspection reduces scope turnaround time and increases availability
Join leading medical facilities worldwide in implementing advanced UV fluorescence technology for endoscope reprocessing verification.
Explore other industries with similar inspection challenges